9/18/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $405.00 | Low | |
9/14/2023 | Stifel Nicolaus | Reiterated Rating | Buy ➝ Buy | $240.00 | Low | |
9/14/2023 | Cantor Fitzgerald | Reiterated Rating | Neutral ➝ Neutral | $190.00 | Low | |
9/12/2023 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $240.00 | Low | |
9/12/2023 | Royal Bank of Canada | Reiterated Rating | Outperform ➝ Outperform | $270.00 | Low | |
8/28/2023 | Royal Bank of Canada | Reiterated Rating | Outperform ➝ Outperform | $270.00 | Low | |
8/18/2023 | Royal Bank of Canada | Reiterated Rating | Outperform ➝ Outperform | $270.00 | Low | |
8/16/2023 | Cantor Fitzgerald | Reiterated Rating | Neutral ➝ Neutral | $190.00 | Low | |
8/8/2023 | Chardan Capital | Reiterated Rating | Buy ➝ Buy | $250.00 | Low | |
8/7/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $405.00 | Low | |
8/4/2023 | Morgan Stanley | Reiterated Rating | Equal Weight ➝ Equal Weight | $210.00 | Low | |
8/4/2023 | Royal Bank of Canada | Reiterated Rating | Outperform ➝ Outperform | $270.00 | Low | |
8/4/2023 | Needham & Company LLC | Reiterated Rating | Buy ➝ Buy | $240.00 | Low | |
8/4/2023 | Citigroup | Boost Target | Buy ➝ Buy | $265.00 ➝ $266.00 | Low | |
7/26/2023 | Sanford C. Bernstein | Lower Target | | $247.00 ➝ $233.00 | Low | |
7/25/2023 | William Blair | Reiterated Rating | Outperform | | Low | |
7/25/2023 | Royal Bank of Canada | Lower Target | Outperform | $275.00 ➝ $270.00 | Low | |
7/25/2023 | HC Wainwright | Lower Target | Buy | $415.00 ➝ $405.00 | Low | |
5/5/2023 | BMO Capital Markets | Upgrade | Market Perform ➝ Outperform | $200.00 ➝ $250.00 | Low | |
4/26/2023 | Sumitomo Mitsui Financial Group | Initiated Coverage | Neutral | $220.00 | Low | |
4/4/2023 | Morgan Stanley | Boost Target | Equal Weight | $205.00 ➝ $210.00 | Low | |
3/21/2023 | Sanford C. Bernstein | Initiated Coverage | Outperform | $243.00 | Low | |
3/3/2023 | JPMorgan Chase & Co. | Lower Target | Neutral | $200.00 ➝ $196.00 | Low | |
3/3/2023 | HC Wainwright | Reiterated Rating | Buy | $415.00 | Low | |
2/24/2023 | Needham & Company LLC | Reiterated Rating | Buy | $240.00 | Low | |
2/24/2023 | Chardan Capital | Reiterated Rating | Buy | $250.00 | Low | |
2/24/2023 | Oppenheimer | Lower Target | Outperform | $256.00 ➝ $249.00 | N/A | |
2/24/2023 | Morgan Stanley | Lower Target | Equal Weight | $210.00 ➝ $205.00 | N/A | |
2/24/2023 | Canaccord Genuity Group | Lower Target | Buy | $310.00 ➝ $291.00 | Low | |
2/24/2023 | Citigroup | Lower Target | Buy | $270.00 ➝ $265.00 | Low | |
2/21/2023 | EF Hutton Acquisition Co. I | Initiated Coverage | Buy | $304.00 | Low | |
1/23/2023 | SVB Leerink | Lower Target | Market Perform | $144.00 ➝ $143.00 | Low | |
1/18/2023 | Canaccord Genuity Group | Initiated Coverage | Buy | $310.00 | Low | |
12/16/2022 | Piper Sandler | Boost Target | Overweight | $226.00 ➝ $253.00 | Low | |
11/7/2022 | SVB Leerink | Boost Target | Market Perform | $142.00 ➝ $145.00 | Low | |
11/2/2022 | HC Wainwright | Lower Target | Buy | $430.00 ➝ $415.00 | N/A | |
10/28/2022 | Barclays | Lower Target | Overweight | $240.00 ➝ $236.00 | Low | |
10/28/2022 | Morgan Stanley | Lower Target | Equal Weight | $220.00 ➝ $210.00 | Low | |
10/28/2022 | The Goldman Sachs Group | Boost Target | Buy | $239.00 ➝ $270.00 | Low | |
10/24/2022 | JPMorgan Chase & Co. | Lower Target | Neutral | $204.00 ➝ $200.00 | Low | |
10/13/2022 | Morgan Stanley | Lower Target | Equal Weight | $222.00 ➝ $220.00 | Low | |
10/3/2022 | Jefferies Financial Group | Boost Target | Buy | $218.00 ➝ $232.00 | Low | |
9/20/2022 | Royal Bank of Canada | Boost Target | Outperform | $225.00 ➝ $250.00 | Low | |
9/9/2022 | Morgan Stanley | Reiterated Rating | Equal Weight | $225.00 ➝ $222.00 | Low | |
9/9/2022 | BMO Capital Markets | Boost Target | Market Perform | $192.00 ➝ $200.00 | Low | |
9/9/2022 | Oppenheimer | Boost Target | Outperform | $170.00 ➝ $256.00 | Low | |
8/9/2022 | Evercore ISI | Boost Target | | $252.00 | N/A | |
8/4/2022 | BMO Capital Markets | Boost Target | Market Perform | $166.00 ➝ $192.00 | Low | |
8/4/2022 | Morgan Stanley | Boost Target | Equal Weight | $159.00 ➝ $225.00 | N/A | |
8/4/2022 | Chardan Capital | Boost Target | Buy | $200.00 ➝ $250.00 | Low | |
8/4/2022 | Needham & Company LLC | Boost Target | Buy | $205.00 ➝ $240.00 | Low | |
8/4/2022 | Citigroup | Boost Target | | $206.00 ➝ $280.00 | Low | |
7/29/2022 | Morgan Stanley | Lower Target | Equal Weight | $164.00 ➝ $159.00 | Low | |
7/29/2022 | Citigroup | Lower Target | | $211.00 ➝ $206.00 | Low | |
7/15/2022 | Morgan Stanley | Lower Target | Equal Weight | $170.00 ➝ $164.00 | Low | |
7/12/2022 | Cantor Fitzgerald | Initiated Coverage | Neutral | $175.00 | N/A | |
6/27/2022 | Guggenheim | Downgrade | Buy ➝ Neutral | | Low | |
6/16/2022 | Needham & Company LLC | Initiated Coverage | Buy | $205.00 | High | |
6/15/2022 | SVB Leerink | Boost Target | Market Perform | $96.00 ➝ $98.00 | High | |
6/7/2022 | William Blair | Initiated Coverage | Outperform | | Medium | |
5/2/2022 | HC Wainwright | Boost Target | | $400.00 ➝ $430.00 | Medium | |
4/29/2022 | Citigroup | Lower Target | | $223.00 ➝ $211.00 | High | |
4/25/2022 | Morgan Stanley | Downgrade | Overweight ➝ Equal Weight | $210.00 ➝ $178.00 | Medium | |
4/12/2022 | HC Wainwright | Boost Target | Buy | $350.00 ➝ $400.00 | Medium | |
4/6/2022 | Oppenheimer | Reiterated Rating | Outperform | $205.00 | Low | |
3/24/2022 | Stifel Nicolaus | Reiterated Rating | Buy | $215.00 | Low | |
2/28/2022 | Citigroup | Initiated Coverage | Buy | $223.00 | High | |
2/23/2022 | Morgan Stanley | Lower Target | Overweight | $215.00 ➝ $210.00 | Low | |
2/11/2022 | Chardan Capital | Reiterated Rating | Buy | $200.00 | Medium | |
2/11/2022 | SVB Leerink | Lower Target | Market Perform | $109.00 ➝ $103.00 | Medium | |
2/3/2022 | Guggenheim | Upgrade | Neutral ➝ Buy | $170.00 | Low | |
1/28/2022 | SVB Leerink | Boost Target | Market Perform | $108.00 ➝ $109.00 | High | |
1/20/2022 | HC Wainwright | Boost Target | Buy | $250.00 ➝ $350.00 | High | |
1/18/2022 | Morgan Stanley | Lower Target | Overweight | $226.00 ➝ $215.00 | High | |
1/3/2022 | Bank of America | Reiterated Rating | Buy ➝ Buy | $211.00 | Medium | |
1/3/2022 | Piper Sandler | Upgrade | Neutral ➝ Overweight | $181.00 ➝ $208.00 | Low | |
12/30/2021 | Oppenheimer | Reiterated Rating | Outperform | $200.00 | Low | |
12/1/2021 | SVB Leerink | Reiterated Rating | Hold | | Medium | |
11/22/2021 | Needham & Company LLC | Boost Target | Buy | $180.00 ➝ $205.00 | High | |
11/22/2021 | The Goldman Sachs Group | Upgrade | Neutral ➝ Buy | $273.00 | High | |
11/22/2021 | Royal Bank of Canada | Upgrade | Sector Perform ➝ Outperform | $144.00 ➝ $225.00 | High | |
11/1/2021 | Oppenheimer | Upgrade | Market Perform ➝ Outperform | $200.00 | Low | |
10/31/2021 | BMO Capital Markets | Reiterated Rating | Hold ➝ Neutral | | Medium | |
10/29/2021 | Morgan Stanley | Lower Target | Overweight | $242.00 ➝ $226.00 | High | |
10/29/2021 | Chardan Capital | Boost Target | Buy | $190.00 ➝ $200.00 | High | |
10/29/2021 | Cantor Fitzgerald | Boost Target | Overweight | $202.00 ➝ $275.00 | Low | |
10/28/2021 | SVB Leerink | Boost Target | Market Perform | $104.00 ➝ $108.00 | High | |
10/18/2021 | SVB Leerink | Reiterated Rating | Market Perform | | Low | |
10/12/2021 | Morgan Stanley | Boost Target | Overweight | $234.00 ➝ $242.00 | Low | |
10/4/2021 | UBS Group | Upgrade | Neutral ➝ Buy | $141.00 ➝ $215.00 | Low | |
8/27/2021 | BMO Capital Markets | Boost Target | Neutral ➝ Market Perform | $174.00 ➝ $196.00 | Medium | |
8/13/2021 | HC Wainwright | Boost Target | Buy | $235.00 ➝ $250.00 | High | |
8/4/2021 | Chardan Capital | Reiterated Rating | Buy | $190.00 | Medium | |
8/4/2021 | Morgan Stanley | Boost Target | Overweight | $224.00 ➝ $234.00 | High | |
8/4/2021 | Barclays | Boost Target | Overweight | $196.00 ➝ $216.00 | High | |
8/4/2021 | Piper Sandler | Downgrade | Overweight ➝ Neutral | $45.00 ➝ $47.00 | High | |
7/16/2021 | Morgan Stanley | Boost Target | Overweight | $205.00 ➝ $224.00 | High | |
4/30/2021 | Morgan Stanley | Lower Target | Overweight | $206.00 ➝ $205.00 | Low | |
4/20/2021 | Needham & Company LLC | Reiterated Rating | Buy | | Low | |
3/1/2021 | Guggenheim | Reiterated Rating | Buy ➝ Neutral | $162.00 | Low | |
2/22/2021 | Guggenheim | Downgrade | Buy ➝ Neutral | $162.00 | Medium | |
2/14/2021 | Royal Bank of Canada | Reiterated Rating | Hold | | Low | |
2/12/2021 | Needham & Company LLC | Boost Target | Buy | $160.00 ➝ $180.00 | Low | |
2/12/2021 | Morgan Stanley | Boost Target | Overweight | $203.00 ➝ $206.00 | Low | |
2/12/2021 | Citigroup | Downgrade | Buy ➝ Neutral | $170.00 ➝ $175.00 | Low | |
2/12/2021 | Barclays | Boost Target | Overweight | $162.00 ➝ $196.00 | Low | |
2/12/2021 | HC Wainwright | Boost Target | Buy | $225.00 ➝ $235.00 | Low | |
1/25/2021 | BMO Capital Markets | Downgrade | Outperform ➝ Market Perform | $185.00 ➝ $185.00 | High | |
1/13/2021 | Cowen | Boost Target | In-Line ➝ Outperform | $154.00 ➝ $197.00 | High | |
1/8/2021 | HC Wainwright | Reiterated Rating | Buy | $225.00 | High | |
12/21/2020 | Royal Bank of Canada | Lower Target | Sector Perform | $150.00 ➝ $144.00 | Medium | |
12/17/2020 | Piper Sandler | Boost Target | Overweight | $169.00 ➝ $181.00 | Low | |
11/25/2020 | BMO Capital Markets | Boost Target | | $182.00 ➝ $183.00 | Low | |
11/25/2020 | Morgan Stanley | Boost Target | Overweight | $200.00 ➝ $203.00 | Low | |
11/24/2020 | SVB Leerink | Boost Target | Market Perform | $90.00 ➝ $91.00 | Low | |
11/6/2020 | Morgan Stanley | Boost Target | Overweight | $197.00 ➝ $200.00 | High | |
10/15/2020 | Bank of America | Lower Target | Buy | $160.00 ➝ $157.00 | Low | |
10/12/2020 | Chardan Capital | Reiterated Rating | Buy | | Low | |
9/30/2020 | Oppenheimer | Reiterated Rating | Hold | $156.00 | Medium | |
9/30/2020 | Berenberg Bank | Initiated Coverage | Hold | $145.00 | Medium | |
9/8/2020 | Citigroup | Initiated Coverage | Buy | $170.00 ➝ $170.00 | Low | |
8/24/2020 | HC Wainwright | Reiterated Rating | Buy | | Low | |
8/11/2020 | Oppenheimer | Downgrade | Outperform ➝ Market Perform | $162.00 ➝ $156.00 | Low | |
8/7/2020 | Morgan Stanley | Lower Target | Overweight | $199.00 ➝ $197.00 | Low | |
8/7/2020 | Chardan Capital | Reiterated Rating | Buy | | Low | |
8/7/2020 | SVB Leerink | Boost Target | Market Perform | $89.00 ➝ $90.00 | Low | |
7/20/2020 | BMO Capital Markets | Boost Target | Outperform | $173.00 ➝ $196.00 | High | |
7/15/2020 | Morgan Stanley | Boost Target | Overweight | $162.00 ➝ $199.00 | Low | |
5/28/2020 | UBS Group | Boost Target | Neutral | $111.00 ➝ $122.00 | Low | |
5/12/2020 | Royal Bank of Canada | Initiated Coverage | Sector Perform | $150.00 | Medium | |
5/7/2020 | BMO Capital Markets | Boost Target | Outperform | $145.00 ➝ $171.00 | Low | |
5/7/2020 | Oppenheimer | Boost Target | Outperform | $140.00 ➝ $162.00 | High | |
5/7/2020 | Morgan Stanley | Boost Target | Overweight | $148.00 ➝ $162.00 | High | |
5/7/2020 | Barclays | Boost Target | Overweight | $143.00 ➝ $156.00 | High | |
5/7/2020 | JPMorgan Chase & Co. | Downgrade | Overweight ➝ Neutral | $133.00 ➝ $137.00 | High | |
5/6/2020 | Needham & Company LLC | Boost Target | Buy | $135.00 ➝ $160.00 | High | |
4/24/2020 | Evercore ISI | Initiated Coverage | Buy | $160.00 | Low | |
4/14/2020 | Needham & Company LLC | Reiterated Rating | Buy | $135.00 | High | |
4/14/2020 | Cantor Fitzgerald | Boost Target | | $195.00 ➝ $202.00 | Low | |
4/14/2020 | Piper Sandler | Lower Target | | $147.00 ➝ $142.00 | Medium | |
4/14/2020 | Nomura Securities | Lower Target | Reduce | $75.00 ➝ $74.00 | Medium | |
4/13/2020 | Oppenheimer | Reiterated Rating | Buy | $140.00 | Medium | |
3/19/2020 | Berenberg Bank | Initiated Coverage | Buy | $200.00 | Low | |
3/5/2020 | Cowen | Reiterated Rating | Buy | | Medium | |
3/3/2020 | Piper Sandler | Reiterated Rating | Buy | $155.00 | N/A | |
2/11/2020 | Nomura Securities | Boost Target | Reduce | $62.00 ➝ $75.00 | Medium | |
2/9/2020 | Cowen | Reiterated Rating | Buy | $154.00 | High | |
2/7/2020 | Evercore ISI | Initiated Coverage | Buy | $145.00 | High | |
2/7/2020 | Morgan Stanley | Lower Target | Overweight | $150.00 ➝ $148.00 | Medium | |
2/7/2020 | Chardan Capital | Reiterated Rating | Buy | | High | |
2/7/2020 | Needham & Company LLC | Reiterated Rating | Buy | | High | |
12/19/2019 | Chardan Capital | Boost Target | Buy | $150.00 ➝ $190.00 | Low | |
12/18/2019 | Nomura Securities | Reiterated Rating | Sell | $62.00 | Low | |
12/18/2019 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $159.00 ➝ $176.00 | Medium | |
12/17/2019 | Piper Jaffray Companies | Boost Target | Overweight | $145.00 ➝ $155.00 | Medium | |
12/17/2019 | Morgan Stanley | Boost Target | Overweight | $141.00 ➝ $150.00 | High | |
11/27/2019 | Cantor Fitzgerald | Boost Target | | $150.00 ➝ $159.00 | Low | |
11/21/2019 | BMO Capital Markets | Boost Target | Outperform | $128.00 ➝ $138.00 | High | |
11/21/2019 | Barclays | Boost Target | Overweight | $125.00 ➝ $131.00 | High | |
11/21/2019 | Needham & Company LLC | Initiated Coverage | Buy | $135.00 | Low | |
11/21/2019 | Cantor Fitzgerald | Reiterated Rating | Buy | $150.00 ➝ $159.00 | Low | |
11/19/2019 | Oppenheimer | Initiated Coverage | Outperform | $128.00 ➝ $128.00 | High | |
11/18/2019 | Cowen | Reiterated Rating | Buy | $120.00 | High | |
11/13/2019 | Bank of America | Initiated Coverage | Buy | $110.00 | Low | |
10/31/2019 | Needham & Company LLC | Reiterated Rating | Buy | $135.00 | Low | |
10/8/2019 | Nomura Securities | Set Target | Sell | $62.00 | Low | |
9/10/2019 | Piper Jaffray Companies | Set Target | Buy | $145.00 | High | |
9/4/2019 | UBS Group | Boost Target | Neutral | $95.00 ➝ $96.00 | Low | |
9/3/2019 | Stifel Nicolaus | Set Target | Buy | $116.00 | Low | |
9/3/2019 | Piper Jaffray Companies | Boost Target | Overweight | $142.00 ➝ $145.00 | Medium | |
8/26/2019 | Piper Jaffray Companies | Set Target | Buy | $142.00 | Low | |
8/7/2019 | Barclays | Reiterated Rating | Buy | $125.00 | High | |
8/7/2019 | Morgan Stanley | Lower Target | Overweight | $126.00 ➝ $124.00 | High | |
8/7/2019 | Cowen | Lower Target | Outperform | $147.00 ➝ $120.00 | High | |
5/23/2019 | The Goldman Sachs Group | Reiterated Rating | Neutral ➝ Neutral | $80.00 | Medium | |
5/2/2019 | Morgan Stanley | Set Target | Buy | $126.00 | High | |
5/2/2019 | BMO Capital Markets | Boost Target | Outperform ➝ Outperform | $126.00 ➝ $128.00 | High | |
4/15/2019 | Stifel Nicolaus | Boost Target | Buy ➝ Buy | $110.00 ➝ $116.00 | Low | |
4/15/2019 | Cantor Fitzgerald | Boost Target | Overweight ➝ Overweight | $135.00 ➝ $138.00 | Low | |
4/15/2019 | BMO Capital Markets | Boost Target | Outperform ➝ Outperform | $119.00 ➝ $126.00 | Low | |
4/11/2019 | Evercore ISI | Initiated Coverage | Outperform | $120.00 | Medium | |
4/9/2019 | SVB Leerink | Boost Target | Market Perform | $90.00 | Medium | |
4/9/2019 | BMO Capital Markets | Boost Target | Outperform ➝ Outperform | $106.00 ➝ $119.00 | High | |
4/9/2019 | Cantor Fitzgerald | Reiterated Rating | Buy | $135.00 | Medium | |
4/9/2019 | Chardan Capital | Reiterated Rating | Buy | $150.00 | Medium | |
3/6/2019 | Cowen | Reiterated Rating | Buy | | Low | |
3/6/2019 | Evercore ISI | Upgrade | In-Line ➝ Outperform | | Low | |
3/5/2019 | Morgan Stanley | Upgrade | Equal Weight ➝ Overweight | $122.00 | Low | |
2/8/2019 | Needham & Company LLC | Reiterated Rating | Buy | $135.00 | High | |
2/8/2019 | BMO Capital Markets | Lower Target | Outperform | $106.00 | High | |
2/7/2019 | Cantor Fitzgerald | Reiterated Rating | Buy | $135.00 | High | |
1/23/2019 | UBS Group | Initiated Coverage | Neutral ➝ Neutral | $87.00 | Low | |
1/15/2019 | Piper Jaffray Companies | Lower Target | Overweight | $152.00 | Low | |
12/17/2018 | Guggenheim | Initiated Coverage | Buy | $105.00 | Medium | |
12/7/2018 | Cantor Fitzgerald | Reiterated Rating | Buy | $135.00 | High | |
11/27/2018 | SVB Leerink | Initiated Coverage | Market Perform | $63.00 | Low | |
11/8/2018 | Cantor Fitzgerald | Reiterated Rating | Buy | | N/A | |
10/18/2018 | BMO Capital Markets | Reiterated Rating | Buy | | High | |
10/16/2018 | BMO Capital Markets | Lower Target | Outperform ➝ Outperform | $125.00 ➝ $124.00 | Medium | |
10/1/2018 | Cantor Fitzgerald | Initiated Coverage | Overweight ➝ Overweight | $135.00 | Low | |
9/28/2018 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $93.00 ➝ $87.00 | High | |